Researcher
China Academy of Chinese Medical Sciences
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 10, 2026 · JOURNAL ARTICLE
Frontiers in Physiology
A narrative review synthesizing preliminary open-label clinical evidence and putative mechanisms without new empirical data; the source itself acknowledges small sample sizes, lack of controlled trials, and unresolved safety and dosing questions, positioning propofol as a candidate for future study rather than an established therapeutic.
AUG 7, 2026 · REVIEW
Frontiers in Oncology
Meta-analysis of 16 predominantly single-arm studies (540 patients) reports favorable pooled proportions for sphincter preservation (90%) and R0 resection (98%), but evidence is low-to-moderate certainty without direct RCT comparisons; confirmatory trials needed.